TY - JOUR

T1 - On plasma fractionation treatment and its implications in cells

AU - Gaur, Nishtha

AU - Short, Robert D

AU - Allinson, Sarah

PY - 2022/12/30

Y1 - 2022/12/30

N2 - Here we present a novel plasma treatment regime– plasma fractionation, analogous to the concept of dose fractionation in radiotherapy, which could see application in plasma-based cancer treatment. In plasma fractionation, a single acute dose of plasma is divided into multiple small dosages (fractionated dosages) and administered to the cells in vitro at 24-hour intervals. We utilised a helium plasma jet and studied the effects of plasma fractionation in an immortalised keratinocyte line (HaCaT) and a squamous cell carcinoma line (A431). The effects were assessed over three cell seeding densities – 8000, 3500and 1000 cells/well. Our results show that, at all seeding densities, plasma fractionation produced lower levels of cell death in both cell types compared to the same dose administered as a single plasma treatment. This highlights the potential of plasma fractionation as a potentially safer method to conduct plasma treatments in future. We also show that A431 cells were more sensitive to a single acute plasma treatment than HaCaT cells, at cell densities that are sub-confluent (1000 cells/well). A similar difference in sensitivity between HaCaT cells and A431 cells was not observed on exogenous treatment with hydrogen peroxide, pointing to the importance of other shorter-lived plasma components.

AB - Here we present a novel plasma treatment regime– plasma fractionation, analogous to the concept of dose fractionation in radiotherapy, which could see application in plasma-based cancer treatment. In plasma fractionation, a single acute dose of plasma is divided into multiple small dosages (fractionated dosages) and administered to the cells in vitro at 24-hour intervals. We utilised a helium plasma jet and studied the effects of plasma fractionation in an immortalised keratinocyte line (HaCaT) and a squamous cell carcinoma line (A431). The effects were assessed over three cell seeding densities – 8000, 3500and 1000 cells/well. Our results show that, at all seeding densities, plasma fractionation produced lower levels of cell death in both cell types compared to the same dose administered as a single plasma treatment. This highlights the potential of plasma fractionation as a potentially safer method to conduct plasma treatments in future. We also show that A431 cells were more sensitive to a single acute plasma treatment than HaCaT cells, at cell densities that are sub-confluent (1000 cells/well). A similar difference in sensitivity between HaCaT cells and A431 cells was not observed on exogenous treatment with hydrogen peroxide, pointing to the importance of other shorter-lived plasma components.

U2 - 10.1109/trpms.2022.3178286

DO - 10.1109/trpms.2022.3178286

M3 - Journal article

VL - 7

SP - 96

EP - 102

JO - IEEE Transactions on Radiation and Plasma Medical Sciences

JF - IEEE Transactions on Radiation and Plasma Medical Sciences

IS - 1

ER -